Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

BACKGROUND: This study aims to evaluate differences in the clinical profiles and use of psychiatric services by people with schizophrenia with and without borderline intellectual functioning. Both groups in this study were receiving standard community psychiatric care. METHODS: A naturalistic sample of 372 people with schizophrenia completed the National Adult Reading Test. Data were collected prospectively over 18 months on psychiatric symptoms and service use. Three hundred and thirteen had normal intellectual functioning (mean age 43, range 20-76 years) and 59 had borderline or lower intellectual functioning (mean age 45, range 21-81 years). This was defined by a National Adult Reading Test error score of more than 40. RESULTS: People with borderline or lower intellectual functioning had a lower quality of life, more severe psychotic symptoms, reduced functioning and fewer antidepressant prescriptions. There were no significant differences in service use including hospital admission. CONCLUSIONS: People with schizophrenia and borderline or lower intellectual functioning are a more disabled group within general adult psychiatric services who should be the focus of initiatives for improved service delivery.

Original publication

DOI

10.1111/j.1365-2788.2006.00837.x

Type

Journal article

Journal

J Intellect Disabil Res

Publication Date

04/2006

Volume

50

Pages

288 - 294

Keywords

Activities of Daily Living, Adult, Aged, Aged, 80 and over, Antidepressive Agents, Community Mental Health Services, Comorbidity, Female, Follow-Up Studies, Humans, Intellectual Disability, Intelligence, Male, Mental Health Services, Middle Aged, Patient Admission, Primary Health Care, Prospective Studies, Psychiatric Status Rating Scales, Psychotropic Drugs, Quality of Life, Schizophrenia, Schizophrenic Psychology, Utilization Review